Researchers Homing In On Mechanisms Of Encephalopathic Diseases

Encephalopathic Diseases One of the great biomedical quests of the last 20 years surrounds a handful of rare and mysterious brain diseases that affect humans and a small group of other mammals. An ongoing international research effort is aimed at understanding the mechanism of these neurodegenerative diseases. Recently, this area has been of particular relevance because one of the disorders-mad cow disease-has become a major, well-publicized health problem in Europe. Four encephalopathic disea

Written byKaren Young Kreeger
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Encephalopathic Diseases One of the great biomedical quests of the last 20 years surrounds a handful of rare and mysterious brain diseases that affect humans and a small group of other mammals. An ongoing international research effort is aimed at understanding the mechanism of these neurodegenerative diseases. Recently, this area has been of particular relevance because one of the disorders-mad cow disease-has become a major, well-publicized health problem in Europe.

Four encephalopathic diseases occur in people: Creutzfeldt-Jakob disease (CJD), Gerstmann- Straussler- Scheinker disease (GSS), fatal familial insomnia, and kuru, an ailment once associated with ritualistic cannibalism among Fore highlanders of Papua New Guinea. Related animal diseases include sheep scrapie and bovine spongiform encephalopathy (BSE, or mad cow disease). Other encephalopathic disorders are also found in domestic cats, mink, antelope, and mule deer.

The fatal diseases cause the brain to become pitted, taking on a distinctive spongiform, or Swiss-cheese-like, appearance. Over ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies